The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Travelers Vaccines-Global Market Insights and Sales Trends 2025
Synopsis
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
Travelers are at increased risk for several infections, including familiar infections such as measles that are widely distributed but more common in developing countries. Travelers Vaccines can markedly decrease the risk for many of these infections and are an important part of pretravel preparation.
In this report, the travelers vaccines mainly covers vaccine for hepatitis A, hepatitis B, rabies, typhoid fever, yellow fever, Japanese encephalitis, meningococcal meningitis, cholera, etc.
The global Travelers Vaccines market size is expected to reach US$ 6111.4 million by 2029, growing at a CAGR of 8.8% from 2023 to 2029. The market is mainly driven by the significant applications of Travelers Vaccines in various end use industries. The expanding demands from the Tourists, Students, Workers and Others, are propelling Travelers Vaccines market. Meningococcal Vaccine, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Japanese Encephalitis Vaccine segment is estimated at % CAGR for the next seven-year period.
Merck, GlaxoSmithKline and Sanofi Pasteur are the main manufacturers in the vaccine market, with a market share of more than 60% and a high degree of market concentration. North America and Europe are the main production regions, with market share of more than 40% and 30%.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by End Users. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Travelers Vaccines, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Travelers Vaccines market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Travelers Vaccines market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Travelers Vaccines sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Travelers Vaccines covered in this report include GlaxoSmithKline, Sanofi Pasteur, Merck, Pfizer, CNBG, Sanofi Pasteur MSD, Serum Institute of India and Biokangtai, etc.
The global Travelers Vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GlaxoSmithKline
Sanofi Pasteur
Merck
Pfizer
CNBG
Sanofi Pasteur MSD
Serum Institute of India
Biokangtai
Global Travelers Vaccines market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Travelers Vaccines market, Segment by Type:
Meningococcal Vaccine
Japanese Encephalitis Vaccine
Yellow Fever Vaccine
Hepatitis Vaccine
Cholera Vaccine
Other
Global Travelers Vaccines market, by End Users
Tourists
Students
Workers
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Travelers Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Travelers Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by End Users, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
Travelers are at increased risk for several infections, including familiar infections such as measles that are widely distributed but more common in developing countries. Travelers Vaccines can markedly decrease the risk for many of these infections and are an important part of pretravel preparation.
In this report, the travelers vaccines mainly covers vaccine for hepatitis A, hepatitis B, rabies, typhoid fever, yellow fever, Japanese encephalitis, meningococcal meningitis, cholera, etc.
The global Travelers Vaccines market size is expected to reach US$ 6111.4 million by 2029, growing at a CAGR of 8.8% from 2023 to 2029. The market is mainly driven by the significant applications of Travelers Vaccines in various end use industries. The expanding demands from the Tourists, Students, Workers and Others, are propelling Travelers Vaccines market. Meningococcal Vaccine, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Japanese Encephalitis Vaccine segment is estimated at % CAGR for the next seven-year period.
Merck, GlaxoSmithKline and Sanofi Pasteur are the main manufacturers in the vaccine market, with a market share of more than 60% and a high degree of market concentration. North America and Europe are the main production regions, with market share of more than 40% and 30%.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by End Users. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Travelers Vaccines, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Travelers Vaccines market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Travelers Vaccines market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Travelers Vaccines sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Travelers Vaccines covered in this report include GlaxoSmithKline, Sanofi Pasteur, Merck, Pfizer, CNBG, Sanofi Pasteur MSD, Serum Institute of India and Biokangtai, etc.
The global Travelers Vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GlaxoSmithKline
Sanofi Pasteur
Merck
Pfizer
CNBG
Sanofi Pasteur MSD
Serum Institute of India
Biokangtai
Global Travelers Vaccines market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Travelers Vaccines market, Segment by Type:
Meningococcal Vaccine
Japanese Encephalitis Vaccine
Yellow Fever Vaccine
Hepatitis Vaccine
Cholera Vaccine
Other
Global Travelers Vaccines market, by End Users
Tourists
Students
Workers
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Travelers Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Travelers Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by End Users, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Travelers Vaccines Market Overview
1.1 Travelers Vaccines Product Overview
1.2 Travelers Vaccines Market Segment by Type
1.2.1 Meningococcal Vaccine
1.2.2 Japanese Encephalitis Vaccine
1.2.3 Yellow Fever Vaccine
1.2.4 Hepatitis Vaccine
1.2.5 Cholera Vaccine
1.2.6 Other
1.3 Global Travelers Vaccines Market Size by Type
1.3.1 Global Travelers Vaccines Market Size Overview by Type (2018-2029)
1.3.2 Global Travelers Vaccines Historic Market Size Review by Type (2018-2023)
1.3.3 Global Travelers Vaccines Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Travelers Vaccines Sales Breakdown by Type (2018-2023)
1.4.2 Europe Travelers Vaccines Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Travelers Vaccines Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Travelers Vaccines Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Travelers Vaccines Sales Breakdown by Type (2018-2023)
2 Global Travelers Vaccines Market Competition by Company
2.1 Global Top Players by Travelers Vaccines Sales (2018-2023)
2.2 Global Top Players by Travelers Vaccines Revenue (2018-2023)
2.3 Global Top Players by Travelers Vaccines Price (2018-2023)
2.4 Global Top Manufacturers Travelers Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 Travelers Vaccines Market Competitive Situation and Trends
2.5.1 Travelers Vaccines Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Travelers Vaccines Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Travelers Vaccines as of 2022)
2.7 Date of Key Manufacturers Enter into Travelers Vaccines Market
2.8 Key Manufacturers Travelers Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Travelers Vaccines Status and Outlook by Region
3.1 Global Travelers Vaccines Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Travelers Vaccines Historic Market Size by Region
3.2.1 Global Travelers Vaccines Sales in Volume by Region (2018-2023)
3.2.2 Global Travelers Vaccines Sales in Value by Region (2018-2023)
3.2.3 Global Travelers Vaccines Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Travelers Vaccines Forecasted Market Size by Region
3.3.1 Global Travelers Vaccines Sales in Volume by Region (2024-2029)
3.3.2 Global Travelers Vaccines Sales in Value by Region (2024-2029)
3.3.3 Global Travelers Vaccines Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Travelers Vaccines by End Users
4.1 Travelers Vaccines Market Segment by End Users
4.1.1 Tourists
4.1.2 Students
4.1.3 Workers
4.1.4 Others
4.2 Global Travelers Vaccines Market Size by End Users
4.2.1 Global Travelers Vaccines Market Size Overview by End Users (2018-2029)
4.2.2 Global Travelers Vaccines Historic Market Size Review by End Users (2018-2023)
4.2.3 Global Travelers Vaccines Forecasted Market Size by End Users (2024-2029)
4.3 Key Regions Market Size Segment by End Users
4.3.1 North America Travelers Vaccines Sales Breakdown by End Users (2018-2023)
4.3.2 Europe Travelers Vaccines Sales Breakdown by End Users (2018-2023)
4.3.3 Asia-Pacific Travelers Vaccines Sales Breakdown by End Users (2018-2023)
4.3.4 Latin America Travelers Vaccines Sales Breakdown by End Users (2018-2023)
4.3.5 Middle East and Africa Travelers Vaccines Sales Breakdown by End Users (2018-2023)
5 North America Travelers Vaccines by Country
5.1 North America Travelers Vaccines Historic Market Size by Country
5.1.1 North America Travelers Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Travelers Vaccines Sales in Volume by Country (2018-2023)
5.1.3 North America Travelers Vaccines Sales in Value by Country (2018-2023)
5.2 North America Travelers Vaccines Forecasted Market Size by Country
5.2.1 North America Travelers Vaccines Sales in Volume by Country (2024-2029)
5.2.2 North America Travelers Vaccines Sales in Value by Country (2024-2029)
6 Europe Travelers Vaccines by Country
6.1 Europe Travelers Vaccines Historic Market Size by Country
6.1.1 Europe Travelers Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Travelers Vaccines Sales in Volume by Country (2018-2023)
6.1.3 Europe Travelers Vaccines Sales in Value by Country (2018-2023)
6.2 Europe Travelers Vaccines Forecasted Market Size by Country
6.2.1 Europe Travelers Vaccines Sales in Volume by Country (2024-2029)
6.2.2 Europe Travelers Vaccines Sales in Value by Country (2024-2029)
7 Asia-Pacific Travelers Vaccines by Region
7.1 Asia-Pacific Travelers Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific Travelers Vaccines Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Travelers Vaccines Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Travelers Vaccines Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Travelers Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific Travelers Vaccines Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Travelers Vaccines Sales in Value by Region (2024-2029)
8 Latin America Travelers Vaccines by Country
8.1 Latin America Travelers Vaccines Historic Market Size by Country
8.1.1 Latin America Travelers Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Travelers Vaccines Sales in Volume by Country (2018-2023)
8.1.3 Latin America Travelers Vaccines Sales in Value by Country (2018-2023)
8.2 Latin America Travelers Vaccines Forecasted Market Size by Country
8.2.1 Latin America Travelers Vaccines Sales in Volume by Country (2024-2029)
8.2.2 Latin America Travelers Vaccines Sales in Value by Country (2024-2029)
9 Middle East and Africa Travelers Vaccines by Country
9.1 Middle East and Africa Travelers Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa Travelers Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Travelers Vaccines Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Travelers Vaccines Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Travelers Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa Travelers Vaccines Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Travelers Vaccines Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 GlaxoSmithKline
10.1.1 GlaxoSmithKline Company Information
10.1.2 GlaxoSmithKline Introduction and Business Overview
10.1.3 GlaxoSmithKline Travelers Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.1.4 GlaxoSmithKline Travelers Vaccines Products Offered
10.1.5 GlaxoSmithKline Recent Development
10.2 Sanofi Pasteur
10.2.1 Sanofi Pasteur Company Information
10.2.2 Sanofi Pasteur Introduction and Business Overview
10.2.3 Sanofi Pasteur Travelers Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Sanofi Pasteur Travelers Vaccines Products Offered
10.2.5 Sanofi Pasteur Recent Development
10.3 Merck
10.3.1 Merck Company Information
10.3.2 Merck Introduction and Business Overview
10.3.3 Merck Travelers Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Merck Travelers Vaccines Products Offered
10.3.5 Merck Recent Development
10.4 Pfizer
10.4.1 Pfizer Company Information
10.4.2 Pfizer Introduction and Business Overview
10.4.3 Pfizer Travelers Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Pfizer Travelers Vaccines Products Offered
10.4.5 Pfizer Recent Development
10.5 CNBG
10.5.1 CNBG Company Information
10.5.2 CNBG Introduction and Business Overview
10.5.3 CNBG Travelers Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.5.4 CNBG Travelers Vaccines Products Offered
10.5.5 CNBG Recent Development
10.6 Sanofi Pasteur MSD
10.6.1 Sanofi Pasteur MSD Company Information
10.6.2 Sanofi Pasteur MSD Introduction and Business Overview
10.6.3 Sanofi Pasteur MSD Travelers Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Sanofi Pasteur MSD Travelers Vaccines Products Offered
10.6.5 Sanofi Pasteur MSD Recent Development
10.7 Serum Institute of India
10.7.1 Serum Institute of India Company Information
10.7.2 Serum Institute of India Introduction and Business Overview
10.7.3 Serum Institute of India Travelers Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Serum Institute of India Travelers Vaccines Products Offered
10.7.5 Serum Institute of India Recent Development
10.8 Biokangtai
10.8.1 Biokangtai Company Information
10.8.2 Biokangtai Introduction and Business Overview
10.8.3 Biokangtai Travelers Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Biokangtai Travelers Vaccines Products Offered
10.8.5 Biokangtai Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Travelers Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Travelers Vaccines Industrial Chain Analysis
11.4 Travelers Vaccines Market Dynamics
11.4.1 Travelers Vaccines Industry Trends
11.4.2 Travelers Vaccines Market Drivers
11.4.3 Travelers Vaccines Market Challenges
11.4.4 Travelers Vaccines Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Travelers Vaccines Distributors
12.3 Travelers Vaccines Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
